BioGeneric Pharma (BGP)
Is this your company? Claim this profile
Drug Product
Advanced Modalities
Analytical & Bioanalytical Services
Company Overview
About
BioGeneric Pharma (BGP) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Cardiovascular
Endocrinology
Quick Facts
HQ:Egypt
Founded:1998
Employees:463
Capabilities & Services
Core Capabilities
- Sterile Injectable
- Sterile Fill/Finish
- Fill/Finish (Vials)
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Cartridge / Pen
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Pilot Scale
Clinical
Commercial Scale
Markets Served
Asia-Pacific
Regulatory Approvals
Drug Approval L6NXUQ
PMDA · #APR-KYY219DP · 2020-07-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-2QCN1SEE
Issued: 2020-01-13
Expires: 2025-04-20
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-GOBHNFRC
Issued: 2020-05-02
Expires: 2025-04-04
Loading CDMO intelligence...
Key facts about BioGeneric Pharma (BGP)
- BioGeneric Pharma (BGP) is headquartered in Egypt.
- BioGeneric Pharma (BGP) was founded in 1998.
- BioGeneric Pharma (BGP) has 463 employees.
- BioGeneric Pharma (BGP)'s capabilities include Sterile Injectable, Sterile Fill/Finish and Fill/Finish (Vials).
Find CDMOs like BioGeneric Pharma (BGP)
Directory pages this company appears in, each with the full list of matching manufacturers.